Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
Clinical trial NCT00604214 · COMPLETED
Trial details
- NCT number
- NCT00604214
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2011-09-01
- Enrollment
- 1696
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.